Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 1055-1057, 2004; 10.1373/clinchem.2004.031260
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ng, E. K.O.
Right arrow Articles by Lo, Y.M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, E. K.O.
Right arrow Articles by Lo, Y.M. D.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2004;50:1055-1057.)
© 2004 American Association for Clinical Chemistry, Inc.


Technical Briefs

Evaluation of Human Chorionic Gonadotropin ß-Subunit mRNA Concentrations in Maternal Serum in Aneuploid Pregnancies: A Feasibility Study

Enders K.O. Ng1, Ahmad El-Sheikhah2, Rossa W.K. Chiu1, K.C. Allen Chan1, Matthew Hogg2, Renu Bindra2, Tse N. Leung3, Tze K. Lau3, Kypros H. Nicolaides2 and Y.M. Dennis Lo1,a

Departments of1 Chemical Pathology and 3 Obstetrics & Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR;2 Harris Birthright Research Centre for Fetal Medicine, King’s College Hospital, London, United Kingdom

aaddress correspondence to this author at: Department of Chemical Pathology, The Chinese University of Hong Kong, Room 38023, 1/F Clinical Sciences Bldg., Prince of Wales Hospital, 30-32 Ngan Shing St., Shatin, New Territories, Hong Kong Special Administrative Region, China; e-mail loym@cuhk.edu.hk

The first 20% of the full text of this article appears below.

The recent demonstration of detectable circulating fetal RNA in maternal plasma (1)(2) has led to the development of new, noninvasive prenatal diagnostic opportunities (3)(4). Unlike fetal DNA measurements in maternal plasma/serum, quantitative analysis of circulating fetal RNA has the advantage of being applicable to all pregnant women irrespective of fetal gender and genetic polymorphism status. In addition, the unexpected stability of circulating RNA has enhanced the practicality of this approach (2)(5)(6). Previously, we developed a real-time quantitative reverse transcription-PCR (RT-PCR) assay for measuring the concentration of human chorionic gonadotropin ß-subunit hCG) mRNA in plasma samples from healthy pregnant women (2). We conducted a case–control study to investigate whether abnormal concentrations of ßhCG mRNA might be detectable in the serum of mothers carrying fetuses with trisomy 21 and trisomy 18.

We sought informed consent from pregnant women who presented for aneuploidy screening at the King’s College Hospital London in the United Kingdom between January and August 2003. Ethics approval was obtained from the Institutional Review Board. Among women who underwent chorionic villous sampling for fetal karyotyping as a result of clinical indications, 149 women consented to blood sampling for ßhCG mRNA measurements. Maternal blood samples were collected into plain tubes immediately before chorionic villous sampling. The blood samples were centrifuged at 1600g for 10 min at 4 °C. The serum was carefully transferred into plain polypropylene tubes, and 3.2 mL was immediately stored in 4 mL of Trizol and kept at –80 °C until RNA extraction. Serum . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
S. S.C. Chim, T. K.F. Shing, E. C.W. Hung, T.-y. Leung, T.-k. Lau, R. W.K. Chiu, and Y.M. Dennis Lo
Detection and Characterization of Placental MicroRNAs in Maternal Plasma
Clin. Chem., March 1, 2008; 54(3): 482 - 490.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
N. B. Y TSUI and Y. M DENNIS LO
Placental RNA in Maternal Plasma: Toward Noninvasive Fetal Gene Expression Profiling.
Ann. N.Y. Acad. Sci., September 1, 2006; 1075: 96 - 102.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
B. C.K WONG and Y.M DENNIS LO
Plasma RNA Integrity Analysis: Methodology and Validation.
Ann. N.Y. Acad. Sci., September 1, 2006; 1075: 174 - 178.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. W.K. Chiu, W.-b. Lui, M.-c. Cheung, N. Kumta, A. Farina, I. Banzola, S. Grotti, N. Rizzo, C. J. Haines, and Y.M. D. Lo
Time Profile of Appearance and Disappearance of Circulating Placenta-Derived mRNA in Maternal Plasma
Clin. Chem., February 1, 2006; 52(2): 313 - 316.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. C.K. Wong, R. W.K. Chiu, N. B.Y. Tsui, K.C. A. Chan, L. W. Chan, T. K. Lau, T. N. Leung, and Y.M. D. Lo
Circulating Placental RNA in Maternal Plasma Is Associated with a Preponderance of 5' mRNA Fragments: Implications for Noninvasive Prenatal Diagnosis and Monitoring
Clin. Chem., October 1, 2005; 51(10): 1786 - 1795.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Y.M. D. Lo
Recent Advances in Fetal Nucleic Acids in Maternal Plasma
J. Histochem. Cytochem., March 1, 2005; 53(3): 293 - 296.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
X. Y. Zhong, W. Holzgreve, I. Hoesli, and S. Hahn
Circulatory Corticotropin-Releasing Hormone mRNA Concentrations Are Increased in Women with Preterm Delivery But Not in Those Who Respond to Tocolytic Treatment
Clin. Chem., March 1, 2005; 51(3): 635 - 636.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
S. K. R. Chinnapapagari, W. Holzgreve, O. Lapaire, B. Zimmermann, and S. Hahn
Treatment of Maternal Blood Samples with Formaldehyde Does Not Alter the Proportion of Circulatory Fetal Nucleic Acids (DNA and mRNA) in Maternal Plasma
Clin. Chem., March 1, 2005; 51(3): 652 - 655.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.